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Abstract 
 
The genomic sequence of a novel gyrovirus (GyV) 3 strain was detected from the fecal sample of a pet ferret. 
The length (2359 nt) and the basic genomic structure of this strain was very similar to that of the single known 
GyV3 reference strain, whereas the genome sequence identity between the two strains was only 76%. Similarly, 
moderate sequence homology was found within the predicted protein coding regions, VP1 (nt, 72%; aa, 76%), 
VP2 (nt, 84%; aa, 85%) and VP3 (nt, 85%; aa, 73%). Sequence identities were lower when comparing our strain 
with other GyV species (48-65% genome-wide nt identity). Phylogenetic analysis of the coding regions clustered 
the ferret origin GyV3 strain within Clade A. Although the available whole genomic sequence of novel GyVs 
permits limited conclusions to be drawn regarding the classification of the Hungarian GyV3 strain, our data 
indicate that this novel strain may be considered as a new genotype within GyV3. Further investigations are 
needed to reveal the genetic diversity and biological properties of newly described members of the Gyrovirus 
genus. 
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Introduction 
 
Gyroviruses (GyVs) comprise a genus (Gyrovirus) within the family Circoviridae. The prototype GyV 
species, Chicken anaemia virus (CAV), causes significant losses in young chickens. Candidate new GyV 
species, including human GyV/avian GyV 2 (HGyV/AGV2), GyV3 to GyV6, have been first identified from 
chicken serum and/or human skin and fecal samples  [1–5]. So far, the etiologic role of novel GyVs in any 
disease has not been formally demonstrated [1–7]. The ssDNA genome of GyVs encodes two or three potential 
proteins and based on phylogenetic analysis they have been grouped into two major clades; members of Clade A 
GyVs possess a larger genome (2315-2383 nt) and include HGyV/AGV2, GyV3 and GyV6 along with the CAV, 
whereas Clade B includes GyV4 and GyV5, both with a smaller genome (2020-2034 nt) [1–5]. 
In a previous study traces of CAV, HGyV/AGV2, GyV3 and GyV4 were detected in the fecal samples 
of pet ferrets (Mustela putorius furo) by viral metagenomics and by diagnostic PCRs [8]; however, discrepancy 
in the positivity rate for GyV3 and GyV4 was seen when the results obtained by the two methods were merged, 
probably due to the extensive sequence variability. A partial fragment of a distant relative of GyV3 was also 
detected by deep sequencing, but could not be fully analysed because of issues in whole genome amplification 
and sequencing. Since then the whole genomic sequence of the novel GyV3 strain was completed and in this 
study we describe the striking genomic and genetic features of this strain. 
 
Results and discussion 
 
Back-to-back PCR primers were designed to amplify the genome of the novel GyV strain, G19. 
However, contrary to our previous study [8], this approach worked only when the modified nucleotide, 7-deaza-
dGTP, was incorporated in the back-to-back PCR assay. The PCR mixture contained 50 µM of dATP, dCTP, 
dGTP and dTTP, 50 µM of 7-deaza-dGTP (New England Biolabs), 200 nM of each primers, 1X Phusion Green 
HF Buffer and 0.3 U Phusion DNA polymerase (Thermo Scientific). The cycling profile was basically the same 
as described elsewhere for other GyVs [8], although we used 54 ºC primer annealing temperature in this 
experiment. The ~2.3 kb long PCR products obtained by various combinations of the back-to-back primers were 
purified (Geneaid) from gel slices and then directly sequenced on an ABI PRISM® 3100-Avant Genetic 
Analyzer using the BigDye Terminator v1.1 Cycle Sequencing Kit (Life Technologies), with the addition of 2.5 
µM of 7-deaza-dGTP to the sequencing reactions. The genome sequence of G19 has been deposited in GenBank 
(accession number KM348009). 
The genome length of the novel GyV strain was the same (2359 nt) as that of the single GyV3 reference 
sequence (JQ308210). The overall nt identity was 76% between the two genomes and was lower with other 
members of the genus (HGyV/AGV2 and GyV6, 65%; CAV, 63-64%; GyV4 and GyV5, 48%).  The location 
and structure of the three hypothetical genes (VP1, VP2 and VP3) was comparable, only with 1-3 aa differences 
between the two GyV3 strains (Online Resource Fig. OR1). The intergenic region between the VP3 and VP1 
consisted of one cytosine that was shared among GyV3, HGyV/AGV2 and GyV6 reference strains, whereas 
CAV had a guanosine in this position. The putative VP1 (1398 nt), VP2 (711 nt) and VP3 (372 nt) genes of G19 
shared, respectively, 72%, 84% and 85% nt and 76%, 85% and 73% aa identities with the appropriate genomic 
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regions of the reference GyV3 strain (Online resource Fig. OR2). The aa based phylogenies of the VP1, VP2 and 
VP3 genes using representative strains of the major GyV groups confirmed the previously described 
relationships among all currently known GyVs (Fig. 1) [5]. The aa composition of the genes of GyV4 and GyV5 
markedly differed from other GyVs [5].  
In addition to the distinctive features, the aa sequence alignments revealed some conserved motifs 
across different GyV species. The GyV3 genomes encoded the longest VP1 in the genus (465 aa for strain G19 
and 463 aa for the reference GyV3 strain vs. 352-460 for other GyVs). The motif 
173
WWRWA
177
 within the VP1 
appears to be conserved for all GyVs, whereas other previously described conserved regions had some apparent 
aa changes [5]. GyV3 strains code for the longest VP2 (236 aa for the G19 and 239 for the reference GyV3 strain 
vs. 216-232 for other GyVs) as well with the aa motif 
42
LKKHDSPY
49
, which is shared by all Clade A GyVs. 
Conserved motifs with up to 5 aa were common among Clade A viruses, but only the motif
 123
HWFQ
126
 was 
detected in all sequences, including GyV4 and GyV5. Beside shorter conserved sequences the VP3 of GyV3 and 
HGyV/AGV2 contained the motif 
37
EIQIGXGSTIITXSLPGXASVRVLTTRSA
65
 with only three substitutions 
by homologous aa with similar polarity. In GyV6, this motif had some additional mutations, whereas CAV was 
only distantly related. 
The nt identity in the non-translated region (NTR) of the two GyV3 strains was 88%. This region of the 
G19 strain contained two GC-rich region at nt 120-155 and nt 2296-2359 with 94.4% and 85.9% GC-content, 
respectively, that may be a strong loop-forming segment of the genome (Online Resource Fig. OR3 and OR4). 
The 36 nt long GC-rich region of the G19 was identical with the corresponding region of the reference GyV3 
and GyV6 strains and differed only in one base from CAV. The 64 nt long GC-rich sequence showed 92% 
similarity with the 67 nt long GC-rich region of the reference GyV3 strain. Furthermore, this 5’ GC-rich region 
of the G19 GyV3 NTR well aligned with the GC-rich region of HGyV/AGV2 (61-69 nt long, 88-89% identity), 
GyV6 (partial, 51 nt long sequence, 89% identity) and CAV (66-67 nt long, 84-92% identity) 5’ NTRs. Both 
GyV3 NTRs contained the CAV promoter TGTACAGGGGGGTACGTCA and two repeats of the reverse 
complement of this sequence (TGACGTACCCCCCTGTACA) just upstream of the 19 nt long CAV promoter 
(Online Resource Fig. OR3 and OR4). A short insert, GGGCGG, between the reverse complement and forward 
CAV promoter in the G19 strain genome might serve as a SP1 transcription factor binding site. An insert 
between the CAV direct repeats showed high affinity to SP1 as well [9]; homologous direct repeats of CAV 
containing the oestrogen responsive element-like sequence AGCTCA may have a role in viral transcription and 
replication [9,10].  
The classification of GyV strains is not elaborated. So far, only CAV strains have been classified into 
groups and subgroups (designated A1-A3, B, C, and D1-D2) on the basis of nt phylogenies of the coding region 
[11]. The greatest difference among CAV sequences was 5.2% in the coding region [11]. Similarly, high 
genome-wide identities were described for HGyV/AGV2 strains of distinct geographic and host-species origin 
[8]. Consequently, the >20% nt and/or aa difference in the VP1 and VP3 regions between the two GyV3 strains 
represents a sharp contrast in the intra-species diversity of GyVs and might be challenging to elaborate a uniform 
classification scheme of the genus. In more recent studies circo- and cyclovirus genomes were analysed in order 
to set up the species demarcation criteria. As a result, 75% and 76% species-specific sequence cut-off values 
were proposed for circoviruses and cycloviruses, respectively [12]. A proposal (assigned code 2014.006a-gV) 
submitted to the International Committee on Taxonomy of Viruses for consideration suggested that >20% 
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genome wide sequence divergence may define different circo- and cyclovirus species. Although the Gyrovirus 
genus currently belongs to the Circoviridae family, these demarcation criteria may not be extended automatically 
to this virus group as only limited sequence information is available for the novel GyV species. Among various 
GyVs, at present only the GyV3 species seems to include virus variants with <80% genome wide sequence 
identity, albeit this moderate sequence homology is accompanied with great gene and genome structure 
similarity. Thus, we tentatively may classify the strain G19 as a novel genotype within the GyV3 species, which 
would be consistent with the proposal that assigns a new species only when the genome wide nt identity to an 
extant reference strain is lower than 75% [13]. Similarly, the genome of GyV4 strain G14 showed a genome-
wide identity of 90.7% with the only GyV4 reference sequence (JX310702) that was more divergent than the 
sequences of the HGyV/AGV2 species [8] and may also represent a new genotype within the GyV4 species. 
In conclusion, in this study we reported the genome of a putative new GyV3 genotype. So far GyV3 has 
been described only from a child with unexplained diarrhea [3]; however, it should be noted that only few 
studies investigated the prevalence of new GyVs in host species other than humans [4, 14-15]. The GyV strains 
we analysed in this and a previous study were detected in the fecal samples of pet ferrets where chicken meat as 
their food may be the source of GyVs. Further investigations are needed to provide more precise estimations of 
the genetic diversity, and to describe the biological properties and the host spectrum of the novel members of 
GyVs. 
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Figure legends 
 
Fig. 1 
Maximum likelihood phylogenetic trees of VP1 (a), VP2 (b), VP3 (c) generated from the aa sequences of 
gyroviruses (GyV) using the LG substitution model for VP1 and VP3, and JTT substitution model for VP2 as 
implemented in MEGA 6 (http://www.megasoftware.net/). Bootstrap values >60% are shown. Scale bars are 
proportional to the genetic distance. Circles indicate the Hungarian GyV strains. GenBank accession numbers of 
the reference human gyrovirus/avian gyrovirus 2 (HGyV/AGV2), GyV1-6 and Chicken Anaemia Virus (CAV) 
strains are indicated in the phylogenetic trees 
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